ReDirection - Self Help Program for Minor Attracted Individuals (ReDirection)

November 13, 2023 updated by: Christoffer Rahm, Karolinska Institutet

A Multicenter, Waitlist Controlled, Randomized Clinical Trial of the Effectiveness of a Self Help Program Based on Cognitive Behavioral Therapy for Individuals With Sexual Urges Involving Minors.

The overall aim of the study is to evaluate the effectiveness of the ReDirection program for individuals with low or medium risk to commit child sexual abuse.

Primary question: Is ReDirection a feasible, effective, and safe method in reducing low to medium risk participants' use of CSAM and related behaviors?

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The present research project aims to contribute to the further development of accessible, evidence-based and safe care for people with concerns about their sexual urges regarding children, and that are using child sexual abuse material (CSAM), so that these people can access treatment according to their needs and level of risk, with the objective of reducing the risk for child sexual abuse and improving the health of the group.

More concretely, we aim to evaluate a revised version of an already available cognitive-behavioral self-help program, ReDirection, with the aim of testing whether this intervention can reduce sexual urges regarding children and CSAM use, in a group of people assessed as being at low or medium risk of committing sexual abuse of children. The intervention will be available in seven languages and will be tested in six countries.

Primary research question: Is ReDirection a feasible, effective, and safe method in reducing low to medium risk participants' use of CSAM and related behaviors?

Secondary research questions: Is ReDirection effective in reducing research subjects' overall risk of committing sexual acts involving children? Does ReDirection reduce specific dynamic risk factors for committing CSA?

ReDirection is based on cognitive behavioral therapy and consists of five modules. The program aims to help participants reduce their CSAM use by gaining a better understanding of, and skills to manage risky sexual thoughts, feelings, and behaviors. At the end of the program, participants are offered an anonymous follow-up chat and if needed during the program, participants can contact a practitioner via chat.

Research subjects will be recruited through Darknet and Clearnet. Darknet refers to websites that are accessible via TOR or similar services. The interventions are provided by practitioners and researchers in the relevant countries.

ReDirection will be evaluated through an international multicenter study using randomized wait-list controlled design.

The research subjects will sign a written consent form on the Iterapi platform without disclosing personal data such as name or location. During the subsequent screening interview via chat or voice call on Iterapi, participation criteria are ensured, questions are answered, and the consent to participate is confirmed. The research subjects are thus admitted to the study.

After inclusion, participants answer the baseline survey which consists of validated self-assessment questionnaires with both multiple choice and free-text answers.

Weekly during, after the waitlist, and after the therapeutic intervention, research subjects answer questions to evaluate the effectiveness and safety of the interventions.

A Statistical Analysis Plan (SAP) based on pilot study is pre-registered at the OSF platform. The SAP describes sample size calculations, and planned analyses of outcome measures.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Klecany, Czechia
        • Recruiting
        • National Institute of Mental Health
        • Contact:
          • Katerina Klapilova, Ass Professor
        • Principal Investigator:
          • Katerina Klapilova, Ass Professor
      • Helsinki, Finland
        • Recruiting
        • Protect Children NGO
        • Contact:
          • Nina Vaarhanen-Valkonen
        • Principal Investigator:
          • Nina Vaarhanen-Valkonen
      • Hamburg, Germany
        • Recruiting
        • [University Medical Center Hamburg-Eppendorf
        • Contact:
          • Peer Briken, Professor
        • Principal Investigator:
          • Peer Briken, Professor
      • Bratislava, Slovakia
        • Recruiting
        • Bratislava Police Academy
        • Contact:
          • Josef Metenko, Professor
        • Principal Investigator:
          • Josef Metenko, Professor
      • Castelló, Spain
        • Recruiting
        • Universitat Jaume I
        • Contact:
          • Rafael Ballester, Professor
        • Principal Investigator:
          • Rafael Ballester, Professor
      • Stockholm, Sweden, 11842
        • Recruiting
        • Centre for psychiatry research, Region Stockholm
        • Contact:
        • Principal Investigator:
          • Christoffer Rahm, MD PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Sufficient language skills: English, Swedish, Finnish, Czech, Slovak, German, or Spanish
  • concern about sexual urges regarding children*,
  • CSAM use past six month
  • Low to medium risk for committing child sexual abuse according to the SChiMRA scale

Exclusion Criteria:

- Participants with a severe psychiatric illness (such as high acute suicide risk or severe substance abuse) will be excluded, or lack of serious intentions to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ReDirection
ReDirection is a self help program based on cognitive behavioral therapy methodology and consists of five modules. The program aims to help participants reduce their CSAM use by gaining a better understanding of, and skills to manage risky sexual thoughts, feelings, and behaviors.
Self help program based on principles for cognitive behavioral therapy
No Intervention: Waitlist
Participants are on a waitlist which means they have no active intervention, only weekly measurements with the same questionnaires as in the active arm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sexual urges involving children
Time Frame: Pre-intervention, during the intervention, and immediately after the intervention.
Measured by Sexual Symptom Assessment Scale (SASS)(0-48 points; higher scores indicate more urges).
Pre-intervention, during the intervention, and immediately after the intervention.
Child sexual abuse material usage
Time Frame: Pre-intervention, during the intervention, and immediately after the intervention.
Measured with Sexual Child Molestation Risk Assessment (SChiMRA+), part B, item 1 (self-reported time spent last week in hours watching CSAM) including 3 follow up questions (about time/day, severity, and of youngest child).
Pre-intervention, during the intervention, and immediately after the intervention.
Other behaviors related to sexual interest in children.
Time Frame: Pre-intervention, during the intervention, and immediately after the intervention.
Time spent last week (hours), as self reported on the SChiMRA+ scale part B, item 4.
Pre-intervention, during the intervention, and immediately after the intervention.
Depressive symtoms
Time Frame: Pre-intervention, and immediately after the intervention.
Scores on the PHQ-9 questionnaire (Patient Health Questionnaire; 0-27 points; higher scores indicate more severe depressive symptoms).
Pre-intervention, and immediately after the intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamic risk for committing child sexual abuse
Time Frame: Pre-intervention, during the intervention,and immediately after the intervention.
Scores on Acute-2007 (21 items; 0-42 points; higher scores indicate higher dynamic risk for committing child sexual abuse)
Pre-intervention, during the intervention,and immediately after the intervention.
Level of hypersexuality
Time Frame: Pre-intervention, and immediately after the intervention.
Scores on the HBI-19 questionnaire (Hypersexual Behavior Inventory; 19-95 points; higher scores indicate higher level of sexuality; more than 52 points indicate hypersexuality)
Pre-intervention, and immediately after the intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 27, 2023

Primary Completion (Estimated)

April 21, 2024

Study Completion (Estimated)

June 30, 2024

Study Registration Dates

First Submitted

October 12, 2023

First Submitted That Met QC Criteria

November 13, 2023

First Posted (Actual)

November 15, 2023

Study Record Updates

Last Update Posted (Actual)

November 15, 2023

Last Update Submitted That Met QC Criteria

November 13, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2023-02321-01
  • 101084355-BRIDGE-ISF-2021 (Other Identifier: European Commission)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pedophilia

Clinical Trials on ReDirection

3
Subscribe